Marta Torrens Melich

Department of Psychiatry and Legal Medicine

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Marta Torrens Melich is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

39 Similar Profiles

1 Finished

EU-MADNESS (EUropean-wide, Monitoring, Analysis and knowledge Dissemination on Novel/Emerging pSychoactiveS): integrated EU NPS monitoring & profiling to prevent health harms and update professionals.
Torrens Melich, M.
European Commission
1/04/14 → 31/03/16
Project

4311 Citations
37 h-Index
130 Article
22 Review article
6 Chapter
1 Book

A multicenter phase II rater-blinded randomized controlled trial to compare the effectiveness of eye movement desensitization reprocessing therapy vs. Treatment as usual in patients with substance use disorder and history of psychological trauma: A study design and protocol
Valiente-Gómez, A., Moreno-Alcázar, A., Radua, J., Hogg, B., Blanco, L., Lupo, W., Pérez, V., Robles-Martínez, M., Torrens, M. & Amann, B. L., 1 Jan 2019, In : Frontiers in Psychiatry. 10, 108.
Research output: Contribution to journal › Article › Research
2 Citations (Scopus)
Dose-Response Pharmacological Study of Mephedrone and Its Metabolites: Pharmacokinetics, Serotoninergic Effects, and Impact of CYP2D6 Genetic Variation
Olesti, E., Farré, M., Carbó, M., Papaseit, E., Perez-Mañá, C., Torrens, M., Yubero-Lahoz, S., Pujadas, M., Pozo, Ó. J. & de la Torre, R., 1 Jan 2019, In : Clinical Pharmacology and Therapeutics. 106, p. 596-604
Research output: Contribution to journal › Article › Research
6 Citations (Scopus)
Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
García-Marchena, N., Barrera, M., Mestre-Pintó, J. I., Araos, P., Serrano, A., Pérez-Mañá, C., Papaseit, E., Fonseca, F., Ruiz, J. J., De Fonseca, F. R., Farré, M., Pavón, F. J. & Torrens, M., 1 Mar 2019, In : PLoS ONE. 14, e0213791.
Research output: Contribution to journal › Article › Research
6 Citations (Scopus)
Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study
Litwin, A. H., Drolet, M., Nwankwo, C., Torrens, M., Kastelic, A., Walcher, S., Somaini, L., Mulvihill, E., Ertl, J. & Grebely, J., 1 Jan 2019, In : Journal of Viral Hepatitis. 26, p. 1094-1104
Research output: Contribution to journal › Article › Research
14 Citations (Scopus)
Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE study
Grebely, J., Drolet, M., Nwankwo, C., Torrens, M., Kastelic, A., Walcher, S., Somaini, L., Mulvihill, E., Ertl, J., Liebert, R. & Litwin, A. H., 1 Jan 2019, In : International Journal of Drug Policy. 63, p. 29-38
Research output: Contribution to journal › Article › Research
8 Citations (Scopus)

EU-MADNESS (EUropean-wide, Monitoring, Analysis and knowledge Dissemination on Novel/Emerging pSychoactiveS): integrated EU NPS monitoring & profiling to prevent health harms and update professionals.

A multicenter phase II rater-blinded randomized controlled trial to compare the effectiveness of eye movement desensitization reprocessing therapy vs. Treatment as usual in patients with substance use disorder and history of psychological trauma: A study design and protocol

Dose-Response Pharmacological Study of Mephedrone and Its Metabolites: Pharmacokinetics, Serotoninergic Effects, and Impact of CYP2D6 Genetic Variation

Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study

Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE study